F-18 FDG Gastric and Anterior Abdominal Muscle Uptake Secondary to Nausea and Vomiting

Abstract

A case is presented of increased fluorine-18 fluorodeoxyglucose (F-18 FDG) uptake in the stomach and the rectus abdominis muscle due to postchemotherapy nausea and vomiting at the time of the 18-FDG injection. This case of abnormal uptake in the stomach and abdomen illustrates the problems that can occur in interpretation.